Autolus Therapeutics PLC banner

Autolus Therapeutics PLC
F:6A3A

Watchlist Manager
Autolus Therapeutics PLC Logo
Autolus Therapeutics PLC
F:6A3A
Watchlist
Price: 1.99 EUR -3.4% Market Closed
Market Cap: €529.2m

Wall St Price Targets

6A3A Price Targets Summary
Autolus Therapeutics PLC

Wall Street analysts forecast 6A3A stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 6A3A is 7.47 EUR with a low forecast of 4.47 EUR and a high forecast of 10.23 EUR.

Lowest Forecast
Price Target
4.47 EUR
125% Upside
Average Forecast
Price Target
7.47 EUR
275% Upside
Highest Forecast
Price Target
10.23 EUR
414% Upside
Autolus Therapeutics PLC Competitors:
Price Targets
FAF
First American Financial Corp
5% Upside

Revenue
Forecast

61% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
61% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 8 years is 40%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 6A3A's stock price target?
Price Target
7.47 EUR

According to Wall Street analysts, the average 1-year price target for 6A3A is 7.47 EUR with a low forecast of 4.47 EUR and a high forecast of 10.23 EUR.

What is the Revenue forecast for Autolus Therapeutics PLC?
Projected CAGR
40%

Over the last 8 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 8 years is 40%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett